Special Offers & Promotions



Latest News



View Channel

New Products



View Channel

Video Presentations



View Channel

Separation Science



View Channel

Microscopy & Image Analysis



View Channel

Laboratory Automation & IT Solutions



View Channel


Chinese Academy of Sciences scientist recognized for his work in medicinal chemistry and drug discovery

publication date: Oct 2, 2019
author/source: Agilent Technologies


Agilent Presents Thought Leader Award to Professor Hualiang Jiang

Agilent Technologies Inc. has announced that Professor Hualiang Jiang has received an Agilent Thought Leader Award. Professor Jiang directs the Shanghai Institute of Materia Medica at the Chinese Academy of Sciences and is a leading researcher in the area of medicinal chemistry and computational drug design.

Professor Jiang has a strong track record identifying new targets for cancer therapy and designing inhibitors that block protein-protein interactions. He and his collaborators designed the first inhibitor of Atox1/CCS and used it to prove that copper chaperones are potential new targets for anticancer therapies. They also designed the first inhibitor of speckle-type POZ protein for potential application to clear-cell renal cell carcinoma.

The Agilent Thought Leader Award will support Professor Jiang in his latest research using novel glycoside-based small molecules to test the potential benefits of an alternative class of inhibitors of the PD-L1/PD-1pathway. His laboratory will measure and compare the metabolic and pharmacologic effects of the small molecule inhibitors against that of benchmark therapeutic PD-L1 antibodies.

"Agilent's support for leading researchers like Professor Jiang underscores our commitment to accelerating the development of metabolomics and integrated biology workflows for cancer drug discovery and characterization," said Victor Chan, Agilent vice president, and general manager of Laboratory Solutions for Agilent Greater China.

"It is my great honor to receive an Agilent Thought Leader Award. As a drug designer, I am interested in discovering novel drug candidates from natural products, in particular, natural carbohydrate compounds, against new drug targets," said Professor Jiang. "Computational drug design and chemical proteomics are the major tools in my research platform. My research team will benefit from the integration of metabolomics data."

The Agilent Thought Leader Award program promotes fundamental scientific advances by contributing financial support, products, and expertise to the research of influential thought leaders in the life sciences, diagnostics, and chemical analysis space. Further information is available at the Agilent Thought Leader Award web page.


About Agilent Technologies

Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to customers' most challenging questions. The company generated revenues of $4.91 billion in fiscal 2018 and employs 15,550 people worldwide.


Company Profile | Recent News

If you have not logged into the website then please enter your details below.


Subscribe to any of our newsletters for the latest on new laboratory products, industry news, case studies and much more!

Newsletters from Lab Bulletin


Request your free copies HERE




Popular this Month

Top 10 most popular articles this month



Today's Picks



Looking for a Supplier?

Search by company or by product


Company Name:






Please note Lab Bulletin does not sell, supply any of the products featured on this website. If you have an enquiry, please use the contact form below the article or company profile and we will send your request to the supplier so that they can contact you directly.

Lab Bulletin is published by newleaf marketing communications ltd.


Media Partners


Exhibitions & Events